MHLW Approves Otsuka Samsca
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labour and Welfare approved Otsuka Pharmaceutical's Samsca (tolvaptan) for the treatment of excess water retention in patients with cardiac failure when other diuretics are ineffective